Category: Postdoc Job

Van Andel Institute – Postdoc Preview

Location: Grand Rapids, Michigan
Application Deadline: 2/24/25

Are you a senior graduate student exploring your postdoc options? VAI Postdoc Preview provides selected applicants the opportunity to visit Van Andel Institute to learn about our postdoctoral training opportunities, meet one-on-one with our internationally recognized faculty and explore our extensive scientific resources, including our state-of-the-art Core Technologies and Services. VAI offers two Postdoc Preview events each year—one in the spring and one in the fall. There is no cost to attend. VAI provides transportation, lodging and meals for all selected applicants. We also are pleased to offer family care grants for those caring for children or other family members.

This application is for VAI’s Spring Postdoc Preview event on May 1 through May 3, 2025. Applications are due by February 24, 2025.

Eligibility
Applicants must be current graduate students at U.S. institutions who anticipate beginning a postdoctoral fellowship within the next year. Individuals who identify as members of underrepresented groups are strongly encouraged to apply. Preference will be given to applicants who are eligible for VAI’s NCI T32-funded Cancer Epigenetics Training Program and VAI’s Inspire Fellowship.Prior to starting the online application, please compile a list of VAI faculty members whose research interests you, along with your curriculum vitae.

About postdoctoral training at VAI
VAI labs conduct world-class biomedical research in cancer epigenetics, neurodegeneration, metabolism, cell biology and structural biology — all supported by outstanding Core Technologies and Services. Postdocs are a crucial part of VAI, so they receive highly competitive salaries, which start at $70,000 per year. VAI also offers postdocs comprehensive benefits, including low-cost health insurance for self and family, paid parental leave, and much more.

We offer numerous fully funded postdoctoral positions across our areas of focus. Learn more about postdoctoral training opportunities at VAI here. In addition, we have two internal fellowship programs: a National Cancer Institute T32-funded Cancer Epigenetics Training (CET) program, and the Inspire Fellowship program for postdocs who identify as underrepresented minorities. Please note that attending Postdoc Preview does not guarantee you a fellowship or a postdoc position at VAI; we encourage you to also apply to one or more of our open postdoc positions and fellowship opportunities (see FAQ tab on the VAI Postdoc Preview webpage for more information).

Questions? Please contact Dr. Erica Gobrogge, program director of VAI’s Office of Postdoctoral Affairs, at [email protected].

About Van Andel Institute
Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to nearly 500 scientists, educators and support staff, who work with national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K–12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology.

About Grand Rapids, MI
Van Andel Institute is in downtown Grand Rapids, Michigan in the center of the Medical Mile. A remarkable combination of a cosmopolitan atmosphere and small-town warmth, Grand Rapids is known for its philanthropic and sustainability-driven community. It’s fun affordable and family-friendly. Located on the banks of the Grand River, Grand Rapids offers all the big-city excitement you’d expect from a million-resident metropolis, featuring hundreds of restaurants and nightspots, theaters, museums, sports and concerts. The safe and clean downtown is surrounded by an eclectic mix of walkable neighborhoods and natural areas.

FLYER

Read More

Winship Cancer Institute of Emory University – Postdoctoral Opportunities in Cancer Research – Recruitment Event 2025

Location – Atlanta, Georgia
Deadline Date: January 10, 2025 EXTENDED to midnight on January 31

Postdoc recruitment event at Emory this Spring! Come check out the opportunities in cancer research at the Winship Cancer Institute! See FLYER for details.

Read More

Washington University St. Louis – Postdoctoral Researcher

Location: St. Louis, Missouri
Application Deadline: December 31, 2025

The Division of Public Health Sciences at Washington University in St. Louis is at the forefront of community-engaged and collaborative research focused on improving health outcomes in Missouri and beyond. Our multidisciplinary faculty conduct cutting-edge research across a wide range of health conditions, with a strong emphasis on the cancer care continuum. We specialize in key areas of public health, including epidemiology, statistics, behavioral science, health equity, and implementation science, driving significant advancements in the field.

The research we’re doing every day leads to better care that changes lives. And the care we provide inspires new, ground-breaking research. This cycle of innovation and compassion drives the Division of Public Health Sciences to redefine the future of public health. Our Division is dedicated to creating an inclusive and supportive environment and we strongly encourage motivated individuals with a background in public health-related fields to apply!

WashU offers postdocs a remarkable, productive training experience. With more than $800M in research support across 3000+ research projects, state-of-the art labs and facilities, world-class libraries, specialized centers, 400+ postdoc faculty mentors across STEM, health, engineering, the social sciences, and the Humanities, and programs tailored to support your path to independence, it’s an amazing time to be a WashU Postdoc! Learn more:

• Postdoc positions are grant funded, including a T32 grant (T32CA190194) from the NCI, with annual stipend starting at $61,508 depending on experience, for 2-3 years of training.
• Support for tuition, books, software, conference travel, and research is available.
• WashU offers excellent benefits.
• Dedicated mentoring and career development.
• Access to grant writing and editorial services to help postdocs craft compelling grant proposals, identify relevant funding opportunities, and navigate the competitive grant landscape.

After training, our postdocs become influential leaders at the forefront of research, education, science, policy, business, and social change around the globe.

We welcome applicants on a rolling basis. Applicants should send their cover letter, curriculum vitae, and list of professional references to our program leaders: Graham Colditz, MD, DrPH and Aimee James PhD, MPH, MA at [email protected]

FLYER

Read More

Wake Forest University School of Medicine – Postbaccalaureate Fellows

Location: Winston-Salem, North Carolina
Application Deadline Date: February 2025

We are excited to share with you information for an exciting a new postbaccalaureate program in the Department of Cancer Biology (https://school.wakehealth.edu/departments/cancer-biology) at the Wake Forest University School of Medicine. The program called Wake PREP2PhD is intended for those who will graduate in Spring 2025, or who recently graduated, and who want to gain valuable research experience in preparation for entry into a PhD program. Wake PREP2PhD is intending to target students who are historically underrepresented in science, including those from an economically disadvantaged background. 4 fellows will be recruited.

Wake PREP2PhD is a 2-year paid program (starting at $38K/year) where you will work full time in the laboratory doing cancer research, while also receiving important scientific and professional development such as scientific communication, application assistance, peer and professional networking, and more. The selected scholars will earn a stipend, be eligible for healthcare coverage, be provided a laptop (if necessary), and be eligible for financial moving assistance, in addition to rigorous scientific training.

Disease areas in the Department of Cancer Biology cover breast, prostate, lung, brain, leukemia, and other cancers with research topics covering genomics, signaling, therapeutic development, immuno-oncology, microbiome, and metabolism, among other topics.

If you are interested or have questions, please contact the Program Administrator, Kelly McNeal, and Program Director, Dr. Steven Kridel directly at [email protected] and [email protected], respectively. The program application can be accessed at https://redcap.link/Prep2PhD or using the QR code on the attached flyer:

Wake_PREP2PhD_flyer.pdf

Read More

The Philadelphia Postdoc Preview

Location: Philadelphia, Pennsylvania
Held on Tuesday February 11, 2025

Join us to learn about postdoctoral training opportunities in Philadelphia!
The Philadelphia Postdoc Preview event is a collaborative effort to raise awareness about the numerous postdoctoral training opportunities at 8 research institutions across Philadelphia including The Children’s Hospital of Philadelphia, The Drexel University College of Medicine, Fox Chase Cancer Center – Temple Health, Lewis Katz School of Medicine – Temple Health, Monell Chemical Senses Center, Thomas Jefferson University, University of Pennsylvania Biomedical Postdoctoral Programs, and The Wistar Institute.

The next Philadelphia Postdoc Preview will be held on Tuesday February 11, 2025. During the Preview, participants will learn about:
-The various Postdoctoral training programs at participating research institutions
-What to consider when choosing where to train
-How to apply to a postdoc
-What it is like to live and work in Philadelphia?

The goal of the Preview event is to raise awareness of the robust training opportunities in the Philadelphia area. Whether you are interested in studying basic, translational, or clinical research in human or model systems, Philadelphia has lots of options for those interested in expanding their research expertise, developing professional skills needed in today’s job market, and growing a network of engaged and successful colleagues.

The target audience for the Preview event includes senior Ph.D. students (who have passed their qualifying exam or are post-candidacy by the time of the event), recent Ph.D. graduates, or early-career postdoc scholars in science, technology, engineering, math, and medical fields. Postdoctoral opportunities at the participating institutions include basic, translational, and clinical research. Information on clinical residencies and fellowships will NOT be presented.

There is no citizenship requirement to register. We are seeking domestic and international candidates alike!

For more information, go to: https://www.philadelphiapostdoc.com/
FLYER

Read More

University of Minnesota Masonic Cancer Center: Postdoctoral Fellows

Job location: Minneapolis, Minnesota
Application Deadline Date: OPEN

Postdoctoral positions in the Lange Lab: Seeking individuals driven to become future scientists and leaders in the field of hormones and cancer within academic basic and translational research, clinical, educational, regulatory, or other science-related careers.

My research team is focused on the role of steroid hormone receptors (SRs) in hormone-driven cancers. Estrogen receptor (ER) and progesterone receptors (PRs) are context-dependent transcription factors that are essential for development of the breast and reproductive tract. Altered sex hormone levels contribute to cancer risk in these tissues and drive metabolic and cell fate transitions associated with rapid tumor progression. The presence of abnormally activated ERs and imbalanced/activated PR isoforms in SR+ tumors can dramatically influence response to endocrine or other therapies. Our overarching research goal is to better understand how SR+ breast cancers and other hormone-influenced cancers of reproductive tissues escape endocrine (i.e. SR-blocking) or other molecular targeted therapies that primarily target proliferating cells. Strategies aimed at targeting metabolically active, but weakly proliferative or non-proliferative (G0) cancer stem or heterogeneous stem-like cell sub-populations as well as highly migratory dormant or quiescent cells (i.e. living as disseminated “active” G0 cells in the circulation or within distant “cancerized” tissue niches) would provide a powerful complement to existing therapeutic strategies. Novel signaling pathway biomarkers may inform new combination therapies.

Signal transduction is an essential role of SRs. Indeed, all SRs can rapidly activate cytoplasmic protein kinases and act as “growth factor sensors”. In this role, SRs are heavily phosphorylated by mitogenic protein kinases (MAPKs, AKT, CDKs) that are frequently elevated and activated in breast and reproductive tract cancers. Phosphorylation of SRs alters their binding partners and promoter selection and influences cancer cell fate/plasticity by regulating genes that specify proliferative, pro-survival, metabolic, and cancer stem cell programs via expression of both autocrine and paracrine factors. Similarly (i.e. via rapid signaling and phosphorylation events), the glucocorticoid receptor (GR) acts as a sensor for both host (i.e. hormonal) and cellular stress, in the form of local cytokines and/or hypoxic conditions within the tumor microenvironment. Identifying the required kinase and co-activator partners of phospho-SRs will enable the targeting of multiple signaling molecules in addition to SRs, which is predicted to halt cancer metastasis, prevent recurrence, and increase patient survival.

My lab has extensive experience developing and using human cancer cell lines and primary cells, genetically modified mouse models, and human tumor specimens. We have routinely developed new reagents and employed classical biochemistry and molecular biology techniques to study SR action and novel mechanisms of gene regulation that impact breast tumor development and progression, cancer stem cell biology, and endocrine therapy resistance. More recently, we have included significant focus on the development of early SR+ fallopian tube lesions that give rise to high grade serous ovarian cancer. We typically complement in vitro studies focused on the mechanisms of signaling inputs to SR-dependent regulation of transcription with the use of genetically modified mice or human patient derived xenograft (PDX) models maintained in mice.

Ongoing projects encompass the following research themes and their molecular mechanisms:

• ER? and PR isoform signaling cross talk in luminal breast cancer progression
• Ligand-independent actions of p-SRs and p-SR-containing complexes in breast cancer
• Cellular “stress” sensing by phospho-GR in triple negative breast cancer progression
• Novel HIF/GR-induced signaling pathways mediated by Breast Tumor Kinase/PTK6
• Fallopian tube transformation and early SR+ serous ovarian cancer progression
• Cell fate plasticity (cell cycle exit/entry into G0) and breast cancer stem cell biology
• Mechanisms of and biological role of cancer cell dormancy/quiescence and senescence
• SR and signaling pathway regulation of breast cancer stem cell populations and biology
• Inflammatory and tumor microenvironmental inputs to altered SR signaling in SR+ tumors
• Breast cancer metastatic cell dissemination as circulating tumor cell/stem cell clusters

SEND CV and list of 2-3 references to Dr. Carol A. Lange at [email protected]

PDF version

Read More

City of Hope: Cancer Metabolism Training Program – Postdoctoral Fellows

Location: Duarte, California

The NIH-funded Cancer Metabolism Training Program (CMTP; T32CA221709) at City of Hope requests applications from postdoctoral fellows desiring innovative training at the intersection of cancer biology and metabolism. Fellows must be NIH training grant eligible and can be supported for up to three years with a competitive stipend and additional funds for travel, research expenses, and childcare. We are particularly interested in applications from fellows from underrepresented groups in order to increase the diversity in the biomedical research workforce. Additional details can be found in this FLYER.

Find additional information on City of Hope’s Postdoctoral Training Programs at: https://www.cityofhope.org/academics/irell-and-manella-graduate-school-of-biological-sciences/postdoctoral-training-office/postdoctoral-training-programs

Read More

Van Andel Institute: Postdoctoral Fellow, Cancer Epigenetics Training Program

Location: Grand Rapids, Michigan
Application Deadline: N/A

Looking for world-class postdoctoral training in cancer epigenetics?

Van Andel Institute is an internationally recognized center of excellence for basic and translational epigenetics research. The Institute’s Cancer Epigenetics Training (CET) program prepares postdoctoral fellows to become independent research leaders in the field of cancer epigenetics. The program offers cutting-edge, interdisciplinary research training in structural and functional aspects of epigenetics, complemented by state-of-the-art Core Technologies and Services, unique professional development activities, and integration with established translational research programs and partnerships led by VAI investigators. Fellows will emerge from the program with comprehensive training in cancer epigenetics and a professional foundation from which to launch their independent biomedical research careers. You can learn more about the program and apply, visit bit.ly/VAICETP FLYER (PDF)

Who is eligible to apply for the Cancer Epigenetics Training program?

Applicants must be near completion of a Ph.D., M.D. or other appropriate terminal degree in a scientific discipline that provides broad training in molecular biology, genetics, and/or biochemistry. Applicants must be U.S citizens or permanent residents. Individuals who identify as underrepresented minorities are strongly encouraged to apply.

Questions are welcome! Please contact Dr. Erica Gobrogge, a member of the Cancer Epigenetics Training Program leadership team and program director of VAI’s Office of Postdoctoral Affairs, at [email protected].

About postdoctoral training at VAI

VAI labs conduct world-class biomedical research in cancer epigenetics, neurodegeneration, metabolism, cell biology and structural biology — all supported by outstanding Core Technologies and Services. Postdocs are a crucial part of VAI, so they receive highly competitive salaries, which start at $70,000 per year. VAI also offers postdocs comprehensive benefits, including low-cost health insurance for self and family, paid parental leave, and much more.

About Van Andel Institute Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to nearly 500 scientists, educators and support staff, who work with national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K–12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology.

About Grand Rapids, Michigan Van Andel Institute is in downtown Grand Rapids, Michigan in the center of the Medical Mile.  A remarkable combination of a cosmopolitan atmosphere and small-town warmth, Grand Rapids is known for its philanthropic and sustainability-driven community. It’s fun affordable and family-friendly. Located on the banks of the Grand River, Grand Rapids offers all the big-city excitement you\’d expect from a million-resident metropolis, featuring hundreds of restaurants and nightspots, theatres, museums, sports and concerts. The safe and clean downtown is surrounded by an eclectic mix of walkable neighborhoods and natural areas. The downtown area is often referred to as safe and clean with an eclectic mix of walkable neighborhoods and natural areas.  

The Cancer Epigenetics Training program is supported by a National Cancer Institute T32 training grant (no. T32CA251066). The content is solely the responsibility of VAI and does not necessarily represent the official views of the National Institutes of Health.

Read More